Solid Tumors, Liquid Challenges: The Impact of Coagulation Disorders

Area of Science:

• Oncology
• Hematology
• Internal Medicine

Background:

• Coagulation disorders are significant complications in patients with solid tumors.
• Solid tumors induce a hypercoagulable state via pro-coagulant factors, endothelial activation, and inflammation.
• These disorders impact patient morbidity and mortality outcomes.

Purpose of the Study:

• To review current knowledge on coagulation disorders in solid tumors.
• To highlight the clinical implications of these disorders.
• To emphasize the need for optimized patient management strategies.

Main Methods:

• Literature review of studies on coagulation disorders and solid tumors.
• Analysis of mechanisms linking solid tumors to hypercoagulability.
• Synthesis of information on clinical manifestations and management.

Main Results:

• Coagulation disorders manifest as venous thromboembolism, arterial thromboembolism, thrombotic microangiopathy, or disseminated intravascular coagulation.
• These complications negatively affect surgical interventions and treatment efficacy (chemotherapy, immunotherapy).
• Identifying high-risk patients and implementing prophylactic measures are crucial.

Conclusions:

• Coagulation disorders are a critical concern in solid tumor patients.
• Further research is needed for novel biomarkers and therapeutic agents.
• Optimized management strategies are essential for improving patient outcomes.